
3HI2 D ,53,7.9,0.0003,2.0,7.5,Structure Of The N-Terminal Domain Of The E. Coli Antitoxin Mqsa (YgitB3021) IN COMPLEX WITH THE E. COLI TOXIN MQSR (YgiuB3022)ÿ
3HI2 B ,60,7.4,0.0019,1.9,8.3,Structure Of The N-Terminal Domain Of The E. Coli Antitoxin Mqsa (YgitB3021) IN COMPLEX WITH THE E. COLI TOXIN MQSR (YgiuB3022)ÿ
4DKS A ,30,7.1,0.0032,2.6,0.0,A Spindle-Shaped Virus Protein (Chymotrypsin Treated)
1JPA B ,35,7.0,0.0315,2.1,2.9,Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region
1JPA B 1,34,7.0,0.0026,2.0,2.9,Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region
4FFF C 3,30,7.0,0.0093,1.4,0.0,Crystal Structure Of Levan Fructotransferase From Arthrobacter Ureafaciens
4FFG B 3,31,7.0,0.0093,1.5,0.0,Crystal Structure Of Levan Fructotransferase From Arthrobacter Ureafaciens In Complex With Dfa-Iv
4FFG C 3,30,7.0,0.0046,1.4,0.0,Crystal Structure Of Levan Fructotransferase From Arthrobacter Ureafaciens In Complex With Dfa-Iv
4FFH C 3,30,7.0,0.0040,1.4,0.0,Crystal Structure Of Levan Fructotransferase D54n Mutant From Arthrobacter Ureafaciens In Complex With Sucrose
4FFH D 3,30,7.0,0.0040,1.4,0.0,Crystal Structure Of Levan Fructotransferase D54n Mutant From Arthrobacter Ureafaciens In Complex With Sucrose
4FFI B 3,31,7.0,0.0193,1.4,0.0,Crystal Structure Of Levan Fructotransferase D54n Mutant From Arthrobacter Ureafaciens In Complex With Levanbiose
2GK9 C 1,43,7.0,0.0281,2.6,11.6,Human Phosphatidylinositol-4-Phosphate 5-Kinase, Type Ii, Gamma
4FFH B 3,30,7.0,0.0041,1.4,0.0,Crystal Structure Of Levan Fructotransferase D54n Mutant From Arthrobacter Ureafaciens In Complex With Sucrose
4FFF A 3,34,6.9,0.0077,1.5,2.9,Crystal Structure Of Levan Fructotransferase From Arthrobacter Ureafaciens
4FFG A 3,30,6.9,0.0035,1.4,0.0,Crystal Structure Of Levan Fructotransferase From Arthrobacter Ureafaciens In Complex With Dfa-Iv
4FFF B 3,30,6.9,0.0095,1.4,0.0,Crystal Structure Of Levan Fructotransferase From Arthrobacter Ureafaciens
5DOR D ,26,6.9,0.0080,2.4,3.8,P2 Integrase Catalytic Domain In Space Group P21
5E6R A 2,45,6.8,0.0161,1.8,2.2,Structures Of Leukocyte Integrin Alb2: The Ai Domain, The Headpiece, And The Pocket For The Internal Ligand
5E6S E 2,45,6.8,0.0249,1.8,2.2,Structures Of Leukocyte Integrin Alb2: The Ai Domain, The Headpiece, And The Pocket For The Internal Ligand
3Q6U A 1,40,6.8,0.0175,2.4,7.5,Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated Stateÿ
2ARF A ,41,6.7,0.0075,1.8,2.4,Solution Structure Of The Wilson Atpase N-Domain In The Presence Of Atp
2XQR G 2,32,6.7,0.0247,1.7,9.4,Crystal Structure Of Plant Cell Wall Invertase In Complex With A Specific Protein Inhibitorÿ
5DOR C ,28,6.7,0.0118,2.4,3.6,P2 Integrase Catalytic Domain In Space Group P21
4MLG F 2,35,6.7,0.0061,1.9,0.0,Structure Of Rs223-beta-xylosidase
2LT4 A ,35,6.7,10e-4.6,2.2,11.4,Cdnlnt From Myxoccoccus Xanthus
2QQV A 3,33,6.7,0.0343,1.8,9.1,Crystal Structure Of A Cell-Wall Invertase (E203a) From Arabidopsis Thaliana In Complex With Sucrose
4CI3 A 10,42,6.7,0.0006,1.8,4.8,Structure Of The Ddb1-crbn E3 Ubiquitin Ligase Bound To Pomalidomide
4MLG A 2,35,6.7,0.0229,1.9,0.0,Structure Of Rs223-beta-xylosidase
2KMV A ,47,6.7,0.0328,2.2,8.5,Solution Structure Of The Nucleotide Binding Domain Of The Human Menkes Protein In The Atp-Free Formÿ
3EW2 A ,39,6.6,0.0259,2.3,5.1,Crystal Structure Of Rhizavidin-Biotin Complexÿ
4IWD A 1,34,6.6,0.0454,2.0,2.9,Structure Of Dually Phosphorylated C-met Receptor Kinase In Complex With An Mk-8033 Analog
3VCF B ,35,6.6,0.0171,2.2,2.9,Ssv1 Integrase C-Terminal Catalytic Domain (174-335aa)
4EGW A ,39,6.6,0.0035,1.5,7.7,The Structure Of The Soluble Domain Of Cora From Methanocaldococcus Jannaschii
3AO9 B ,48,6.6,0.0455,2.4,6.2,Crsytal Structure Of The C-Terminal Domain Of Sequence-Specific Ribonucleaseÿ
4YU6 A 4,37,6.6,0.0242,1.7,2.7,Crystal Structure Of Bacillus Anthracis Immune Inhibitor A2 Peptidase
3LC6 A 2,40,6.5,0.0486,2.2,5.0,The Alternative Conformation Structure Of Isocitrate Dehydrogenase KinasePHOSPHATASE FROM E. COLIÿ
2FHZ B ,50,6.5,0.0182,2.1,4.0,Molecular Basis Of Inhibition Of The Ribonuclease Activity In Colicin E5 By Its Cognate Immunity Protein
4CSU K ,31,6.5,0.0317,4.5,9.7,Cryo-em Structures Of The 50s Ribosome Subunit Bound With Obge
1Q99 A 1,35,6.5,0.0047,2.1,5.7,Crystal Structure Of The Saccharomyces Cerevisiae Sr Protein Kinsae, Sky1p, Complexed With The Non-Hydrolyzable Atp Analogue, Amp-Pnp
4GVA A 1,36,6.5,0.0018,1.9,2.8,Adp-Bound Form Of The Erk2 Kinase
2FYS A 1,29,6.4,0.0020,1.5,0.0,Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3
4QP1 B 1,34,6.4,0.0133,1.8,2.9,Crystal Structure Of Erk2 In Complex With N-cyclohexyl-9h-purin-6- Amine
4N4S A 1,34,6.4,0.0154,2.0,5.9,A Double Mutant Rat Erk2 In Complex With A Pyrazolo[3,4-d]pyrimidine Inhibitor
4N4S B 1,34,6.4,0.0156,2.0,5.9,A Double Mutant Rat Erk2 In Complex With A Pyrazolo[3,4-d]pyrimidine Inhibitor
5ETC A 1,31,6.4,0.0166,1.4,6.5,Structure Of Inactive Mapk14 With Ordered Activation Loop
2W9P J ,46,6.4,0.0259,2.4,13.0,Crystal Structure Of Potato Multicystatinÿ
4YNO A 1,30,6.3,0.0178,1.7,10.0,Crystal Structure Of Mapk13 At Inactive Form
2OTR A ,57,6.3,0.0107,2.6,8.8,Solution Structure Of Conserved Hypothetical Protein Hp0892 From Helicobacter Pylori
3A4P A ,30,6.3,0.0460,1.8,3.3,Human C-Met Kinase Domain Complexed With 6- Benzyloxyquinoline Inhibitorÿ
3A4P A 1,31,6.3,0.0032,2.1,3.2,Human C-Met Kinase Domain Complexed With 6- Benzyloxyquinoline Inhibitorÿ
2AGY A 1,40,6.3,0.0194,1.9,15.0,Crystal Structure Of The Schiff Base Intermediate In The Reductive Half-Reaction Of Aromatic Amine Dehydrogenase (Aadh) With Tryptamine. Monoclinic Form
1R4Y A ,31,6.3,0.0116,1.7,6.5,Solution Structure Of The Deletion Mutant Delta(7-22) Of The Cytotoxic Ribonuclease Alpha-Sarcin
2AGX B 1,41,6.3,0.0200,2.0,14.6,Crystal Structure Of The Schiff Base Intermediate In The Reductive Half-Reaction Of Aromatic Amine Dehydrogenase (Aadh) With Tryptamine. P212121 Form
2I0R A 1,41,6.3,0.0203,2.0,14.6,Crystal Structure Of Aromatic Amine Dehydrogenase Ttq- Formamide Adduct
2I0S A 1,41,6.3,0.0203,2.0,14.6,Crystal Structure Of Aromatic Amine Dehydrogenase Ttq- Phenylacetaldehyde Adduct
2B5M A 8,41,6.3,0.0094,2.2,7.3,Crystal Structure Of Ddb1
5FQD D 7,41,6.3,0.0037,2.1,7.3,Structural Basis Of Lenalidomide Induced Ck1a Degradation By The Crl4crbn Ubiquitin Ligase
2DFX E ,50,6.3,0.0455,2.1,4.0,Crystal Structure Of The Carboxy Terminal Domain Of Colicin E5 Complexed With Its Inhibitor
3HLL A 1,32,6.3,0.0038,1.5,6.2,Crystal Structure Of Human P38alpha Complexed With Ph-797804ÿ
1WBP A 1,32,6.3,0.0227,1.8,6.2,Srpk1 Bound To 9mer Docking Motif Peptideÿ

4S33 A 1,36,6.3,0.0231,1.9,2.8,Erk2 R65s Mutant Complexed With Amp-pnp
2W9Q A ,47,6.3,0.0359,2.5,12.8,Crystal Structure Of Potato Multicystatin-P212121ÿ
4XOZ A 1,30,6.3,0.0234,1.7,0.0,Crystal Structure Of Erk2 In Complex With An Inhibitor
2W9P I ,46,6.3,0.0362,2.4,13.0,Crystal Structure Of Potato Multicystatinÿ
4A0K C 12,37,6.2,0.0042,2.0,5.4,Structure Of Ddb1-Ddb2-Cul4a-Rbx1 Bound To A 12 Bp Abasic Site Containing Dna-Duplexÿ
3I7K A 10,39,6.2,0.0044,2.1,7.7,Crystal Structure Of Ddb1 In Complex With The H-Box Motif Of Whxÿ
2HJB B 1,40,6.2,0.0273,1.9,15.0,Crystal Structure Of Alcaligenes Faecalis Aadh In Complex With P-Methoxybenzylamine
3PY3 A 1,32,6.2,0.0274,1.6,6.2,Crystal Structure Of Phosphorylated P38alpha Map Kinaseÿ
2HJ4 B 1,41,6.2,0.0282,2.0,14.6,Crystal Structure Of Alcaligenes Faecalis Aadh Complex With P-Nitrobenzylamine
5DZT A 3,33,6.2,0.0186,2.6,3.0,Crystal Structure Of Class Ii Lanthipeptide Synthetase Cylm In Complex With Amp
2H47 F 1,42,6.2,0.0305,2.0,14.3,Crystal Structure Of An Electron Transfer Complex Between Aromatic Amine Dephydrogenase And Azurin From Alcaligenes Faecalis (Form 1)
2I0R B 1,41,6.2,0.0308,2.0,14.6,Crystal Structure Of Aromatic Amine Dehydrogenase Ttq- Formamide Adduct
2IAA A 1,39,6.2,0.0325,1.9,12.8,Crystal Structure Of An Electron Transfer Complex Between Aromatic Amine Dephydrogenase And Azurin From Alcaligenes Faecalis (Form 2)
4EWQ A 1,29,6.2,0.0337,1.4,6.9,Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor
3ZUV A 1,38,6.2,0.0057,2.0,2.6,Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2
2H3X D 1,41,6.2,0.0345,2.0,14.6,Crystal Structure Of An Electron Transfer Complex Between Aromatic Amine Dehydrogenase And Azurin From Alcaligenes Faecalis (Form 3)
3ZSG A 1,30,6.2,0.0349,1.6,6.7,X-Ray Structure Of P38alpha Bound To Tak-715
5EUT A 1,43,6.2,0.0151,2.1,7.0,Crystal Structure Of Phosphatidyl Inositol 4-kinase Ii Alpha In The Apo State
2H3X A 1,41,6.2,0.0351,2.0,14.6,Crystal Structure Of An Electron Transfer Complex Between Aromatic Amine Dehydrogenase And Azurin From Alcaligenes Faecalis (Form 3)
2H47 D 1,41,6.2,0.0356,2.0,14.6,Crystal Structure Of An Electron Transfer Complex Between Aromatic Amine Dephydrogenase And Azurin From Alcaligenes Faecalis (Form 1)
4E5A X 1,30,6.2,0.0356,1.6,6.7,The W197a Mutant Of P38a Map Kinase
3ZUV C 1,37,6.2,0.0358,1.9,2.7,Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2
4HYU A 1,30,6.2,0.0372,1.6,3.3,Crystal Structure Of Jnk1 In Complex With Jip1 Peptide And 4-{4-[4-(3- Methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan
2ERK A 1,37,6.1,0.0376,1.9,2.7,Phosphorylated Map Kinase Erk2
4IZ7 A 1,36,6.1,0.0378,1.9,2.8,Structure Of Non-phosphorylated Erk2 Bound To The Pea-15 Death Effector Domain
4LOP C 1,30,6.1,0.0393,1.6,6.7,Structural Basis Of Autoactivation Of P38 Alpha Induced By Tab1 (tetragonal Crystal Form)
4J98 B 1,31,6.1,0.0065,2.3,9.7,Crystal Strucure Of Fgf Receptor 2 (fgfr2) Kinase Domain Harboring The Gain-of-function K659q Mutation
3O17 B 1,33,6.1,0.0393,1.7,3.0,Crystal Structure Of Jnk1-Alpha1 Isoformÿ
3MY0 V 1,43,6.1,0.0171,1.9,7.0,Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189ÿ
4QTE A 1,30,6.1,0.0402,1.7,3.3,Structure Of Erk2 In Complex With Vtx-11e, 4-{2-[(2-chloro-4- Fluorophenyl)amino]-5-methylpyrimidin-4-yl}-n-[(1s)-1-(3- Chlorophenyl)-2-hydroxyethyl]-1h-pyrrole-2-carboxamide
3F61 A 1,28,6.1,0.0403,1.7,7.1,Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
1FLO B 2,42,6.1,0.0437,3.0,7.1,Flp Recombinase-Holliday Junction Complex Iÿ
1NB3 K ,33,6.1,0.0193,2.4,3.0,Crystal Structure Of Stefin A In Complex With Cathepsin H: N-Terminal Residues Of Inhibitors Can Adapt To The Active Sites Of Endo-And Exopeptidases
3IPH A 1,29,6.1,0.0414,1.4,6.9,Crystal Structure Of P38 In Complex With A Biphenylamide Inhibitorÿ
1NB3 I ,36,6.1,0.0195,2.7,5.6,Crystal Structure Of Stefin A In Complex With Cathepsin H: N-Terminal Residues Of Inhibitors Can Adapt To The Active Sites Of Endo-And Exopeptidases
5GAI D 1,43,6.1,0.0217,2.5,7.0,Probabilistic Structural Models Of Mature P22 Bacteriophage Portal, Hub, And Tailspike Proteins
1DI9 A 1,31,6.1,0.0073,1.6,6.5,The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline
2H96 B 1,31,6.1,0.0075,1.6,6.5,Discovery Of Potent, Highly Selective, And Orally Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal Kinase Inhibitors
1IR3 A 1,32,6.1,0.0075,1.9,6.2,Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog
4XP0 A 1,29,6.1,0.0461,1.5,0.0,Crystal Structure Of Erk2 In Complex With An Inhibitor
3BEG A 1,32,6.1,0.0469,1.9,6.2,Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2ÿ
1BL7 A 1,31,6.1,0.0473,1.5,6.5,The Complex Structure Of The Map Kinase P38SB220025
3MY0 X 1,41,6.1,0.0212,1.9,7.3,Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189ÿ
3O2M B 1,32,6.1,0.0499,1.8,3.1,Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A Biaryl Tetrazol (A-82118)ÿ
3GC0 A 1,33,6.1,0.0083,1.7,6.1,Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In Complex With Ampÿ
3LVP D 1,30,6.1,0.0084,2.2,6.7,Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitorÿ
2FUM A 1,29,6.1,0.0229,1.5,6.9,Catalytic Domain Of Protein Kinase Pknb From Mycobacterium Tuberculosis In Complex With Mitoxantrone
4AA4 A 1,29,6.0,0.0089,1.4,6.9,P38alpha Map Kinase Bound To Cmpd 22
4FL2 A 4,30,6.0,0.0090,1.6,3.3,Structural And Biophysical Characterization Of The Syk Activation Switch
2B5L A 11,34,6.0,0.0095,1.9,5.9,Crystal Structure Of Ddb1 In Complex With Simian Virus 5 V Protein
3B2T A 1,34,6.0,0.0096,2.1,5.9,Structure Of Phosphotransferase
4GFG A 1,30,6.0,0.0099,1.7,0.0,Crystal Structure Of Spleen Tyrosine Kinase Complexed With R9021
1RQQ A 1,32,6.0,0.0100,1.9,6.2,Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps
4XP3 A 1,29,6.0,0.0100,1.5,0.0,Crystal Structure Of Erk2 In Complex With An Inhibitor
3ROC A 1,30,6.0,0.0105,1.6,6.7,Crystal Structure Of Human P38 Alpha Complexed With A Pyrimidinone Compoundÿ
3CTJ A 1,30,6.0,0.0109,1.7,13.3,Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor
3HV4 B 1,30,6.0,0.0110,1.5,6.7,Human P38 Map Kinase In Complex With Rl51ÿ
4Z7G B 1,26,6.0,0.0299,1.8,3.8,Crystal Structure Of Human Ire1 Cytoplasmic Kinase-rnase Region - Apo
4QP8 B 1,34,6.0,0.0112,1.9,5.9,Crystal Structure Of Erk2 In Complex With 2-(1h-pyrazol-4-yl)-7- (pyridin-3-yl)-5h-pyrrolo[2,3-b]pyrazine
5I0N A 1,47,6.0,0.0310,2.3,2.1,Pi4k Iialpha Bound To Calcium

3MY0 L 1,42,5.9,0.0313,1.9,7.1,Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189ÿ
4L00 B 1,31,5.9,0.0125,2.0,9.7,Crystal Structure Of The Apo Jak1 Pseudokinase Domain
4J95 C 1,32,5.9,0.0126,2.2,12.5,Crystal Strucure Of Fgf Receptor 2 (fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome In Space Group C2
5CY3 A 1,31,5.9,0.0343,1.9,0.0,Syk Catalytic Domain Complexed With A Potent And Orally Bioavailable Benzisothiazole Inhibitor
3BPR D 1,35,5.9,0.0356,1.9,8.6,Crystal Structure Of Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex With Inhibitor C52
3BPR C 1,34,5.9,0.0358,1.9,8.8,Crystal Structure Of Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex With Inhibitor C52
4Z7G A 1,27,5.9,0.0366,1.8,3.7,Crystal Structure Of Human Ire1 Cytoplasmic Kinase-rnase Region - Apo
3GCU B 1,30,5.9,0.0139,1.5,6.7,Human P38 Map Kinase In Complex With Rl48ÿ
1FGK B 1,31,5.9,0.0142,2.3,12.9,Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1
4FVP A 1,30,5.9,0.0381,1.7,13.3,Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form)
4FL3 A 3,30,5.9,0.0152,1.6,3.3,Structural And Biophysical Characterization Of The Syk Activation Switch
1NB5 K ,32,5.9,0.0430,2.7,3.1,Crystal Structure Of Stefin A In Complex With Cathepsin H
1W83 A 1,30,5.9,0.0156,1.5,6.7,P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor
3MY0 P 1,42,5.9,0.0395,2.0,7.1,Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189ÿ
3N9X B 1,32,5.9,0.0157,1.9,3.1,Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0ÿ
1GAG A 1,31,5.9,0.0159,1.8,6.5,Crystal Structure Of The Insulin Receptor Kinase In Complex With A Bisubstrate Inhibitor
2AUH A 1,32,5.9,0.0159,2.0,6.2,Crystal Structure Of The Grb14 Bps Region In Complex With The Insulin Receptor Tyrosine Kinaseÿ
3N9X A 1,33,5.9,0.0160,1.9,3.0,Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0ÿ
4XYF A 1,28,5.9,0.0163,1.8,0.0,Crystal Structure Of C-met In Complex With (s)-5-(8-fluoro-3-(1-(3-(2- Methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6- Yl)-3-methylisoxazole
4XG4 A 1,31,5.9,0.0164,1.8,0.0,Crystal Structure Of An Inhibitor-bound Syk
1TL8 A 3,30,5.9,0.0047,2.4,3.3,Human Dna Topoisomerase I (70 Kda) In Complex With The Indenoisoquinoline Ai-Iii-52 And Covalent Complex With A 22 Base Pair Dna Duplex
1WBN A 1,30,5.9,0.0451,1.6,6.7,Fragment Based P38 Inhibitorsÿ
4IBM A 1,30,5.9,0.0169,1.8,6.7,Crystal Structure Of Insulin Receptor Kinase Domain In Complex With An Inhibitor Irfin-1
4J98 A 1,31,5.8,0.0171,2.2,9.7,Crystal Strucure Of Fgf Receptor 2 (fgfr2) Kinase Domain Harboring The Gain-of-function K659q Mutation
4YZ9 B 1,29,5.8,0.0458,1.7,3.4,Crystal Structure Of Human Phosphorylated Ire1alpha In Complex With A Type Iii Kinase Inhibitor (gsk2850163a)
5EYC A 1,29,5.8,0.0172,1.8,0.0,Crystal Structure Of C-met In Complex With Naphthyridinone Inhibitor 5
2OJI A 1,35,5.8,0.0175,2.0,2.9,Crystal Structure Of Erk2 In Complex With N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
2I2L C 2,29,5.8,0.0473,2.2,24.1,Crystal Structure Of The Hypothetical Protein Yopx From Bacillus Subtilis. Nesg Target Sr411
3TC1 B ,36,5.8,0.0016,1.6,8.3,Crystal Structure Of Octaprenyl Pyrophosphate Synthase From Helicobacter Pyloriÿ
3TC1 B 1,36,5.8,0.0016,1.6,8.3,Crystal Structure Of Octaprenyl Pyrophosphate Synthase From Helicobacter Pyloriÿ
3GQL B 1,31,5.8,0.0179,2.0,6.5,Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substratesÿ
4J96 A 1,30,5.8,0.0180,2.0,3.3,Crystal Strucure Of Fgf Receptor 2 (fgfr2) Kinase Domain Harboring The Pathogenic Gain-of-function K659m Mutation Identified In Cervical Cancer
3C1X A 1,31,5.8,0.0490,1.8,6.5,Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor
4DEI A 1,30,5.8,0.0183,1.8,0.0,Crystal Structure Of C-Met In Complex With Triazolopyridinone Inhibitor 24
1RR8 C 3,33,5.8,0.0053,3.1,9.1,Structural Mechanisms Of Camptothecin Resistance By Mutations In Human Topoisomerase I
1PKG B 1,31,5.8,0.0184,1.9,6.5,Structure Of A C-Kit Kinase Product Complex
3OG7 B 1,32,5.8,0.0185,2.6,6.2,B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032ÿ
4KIQ B 1,29,5.8,0.0186,1.4,6.9,Crystal Structure Of Mitogen-activated Protein Kinase 14 (p38-h5) Complex With Ethyl 6-((5-(cyclopropylcarbamoyl)-2-methylphenyl) Carbamoyl)-1h-indole-1-carboxylate
4YJP A 1,32,5.8,0.0188,1.8,0.0,The Kinase Domain Of Human Spleen Tyrosine (syk) In Complex With Gtc000223
1SEU A 3,30,5.8,0.0054,2.5,3.3,Human Dna Topoisomerase I (70 Kda) In Complex With The Indolocarbazole Sa315f And Covalent Complex With A 22 Base Pair Dna Duplex
3MY0 H 1,39,5.8,0.0483,1.9,5.1,Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189ÿ
3I7N A 11,39,5.8,0.0192,2.1,7.7,Crystal Structure Of Ddb1 In Complex With The H-Box Motif Of Wdtc1ÿ
1IAN A 1,30,5.8,0.0194,1.6,6.7,Human P38 Map Kinase Inhibitor Complex
2OKR D 1,30,5.8,0.0197,1.4,6.7,Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
4KOP C 1,40,5.8,0.0199,2.8,0.0,Crystal Structure Of Why2 From Arabidopsis Thaliana
4ASC A 2,41,5.8,0.0010,2.6,4.9,Crystal Structure Of The Kelch Domain Of Human Kbtbd5
4KIQ C 1,29,5.8,0.0206,1.5,6.9,Crystal Structure Of Mitogen-activated Protein Kinase 14 (p38-h5) Complex With Ethyl 6-((5-(cyclopropylcarbamoyl)-2-methylphenyl) Carbamoyl)-1h-indole-1-carboxylate
4S31 A 1,36,5.8,0.0207,1.9,2.8,Crystal Structure Of Mitogen-activated Protein Kinase 1 Wterk2 At 1.45a
1U2J H 3,33,5.8,0.0303,2.0,6.1,Crystal Structure Of The C-Terminal Domain From The Catalase-Peroxidase Katg Of Escherichia Coli (P21 21 21)
3F66 B 1,30,5.8,0.0215,2.3,3.3,Human C-Met Kinase In Complex With Quinoxaline Inhibitorÿ
2GHM A 1,30,5.8,0.0217,1.6,6.7,Mutated Map Kinase P38 (Mus Musculus) In Complex With Inhbitor Pg-895449
1SC7 A 3,29,5.8,0.0064,2.4,3.4,Human Dna Topoisomerase I (70 Kda) In Complex With The Indenoisoquinoline Mj-Ii-38 And Covalent Complex With A 22 Base Pair Dna Duplex
4J95 A 1,30,5.8,0.0222,1.8,0.0,Crystal Strucure Of Fgf Receptor 2 (fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome In Space Group C2
3VF8 A 1,30,5.8,0.0227,1.9,0.0,Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416
4RWL B 1,30,5.8,0.0231,2.0,6.7,Crystal Structure Of Fgfr1 (c488a, C584c) In Complex With 6-(7-((1- Aminocyclopropyl) Methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1- Naphthamide (e3810)
4H58 A 1,27,5.7,0.0232,1.6,0.0,Braf In Complex With Compound 3
2PWL B 1,32,5.7,0.0246,2.1,3.1,Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome
3BU6 A 1,30,5.7,0.0248,1.9,6.7,Crystal Structure Of The Insulin Receptor Kinase In Complex With Irs2 Krlb Phosphopeptide
1H3Q A ,37,5.7,0.0191,1.8,5.4,Crystal Sturcture Of Sedl At 2.4 Angstroms Resolution
1H3Q A 1,36,5.7,0.0191,1.6,2.8,Crystal Sturcture Of Sedl At 2.4 Angstroms Resolution
